Elisabeth A. Sandoval's most recent trade in Procept BioRobotics Corp was a trade of 2,771 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Procept BioRobotics Corp | Elisabeth A. Sandoval Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 2,771 | 2,771 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Elisabeth A. Sandoval Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 1,538 | 12,561 | - | 0 | Common Stock | |
| VYNE Therapeutics Inc | Elisabeth A. Sandoval Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Procept BioRobotics Corp | Elisabeth A. Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 2,526 | 2,526 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Elisabeth A. Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 1,376 | 11,023 | - | 0 | Common Stock | |
| VYNE Therapeutics Inc | Sandoval-Little A. Elisabeth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| VYNE Therapeutics Inc | A. Elisabeth Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Procept BioRobotics Corp | Elisabeth A. Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 4,865 | 4,865 | - | - | Stock Option (Right to Buy) | |
| Procept BioRobotics Corp | Elisabeth A. Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 2,711 | 9,647 | - | 0 | Common Stock | |
| VYNE Therapeutics Inc | Elisabeth A. Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 20,500 | 20,500 | - | - | Stock Options | |
| Procept BioRobotics Corp | Elisabeth A. Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 4,205 | 4,205 | - | - | Common Stock | |
| Procept BioRobotics Corp | Elisabeth A. Sandoval-Little | Director | Grant, award, or other acquisition of securities at price $ 37.48 per share. | 07 Jun 2022 | 2,001 | 6,936 | - | 37.5 | 74,997 | Common Stock |
| Procept BioRobotics Corp | A. Sandoval-Little Elisabeth | Director | Grant, award, or other acquisition of securities at price $ 40.46 per share. | 21 Oct 2021 | 4,935 | 4,935 | - | 40.5 | 199,670 | Common Stock |
| VYNE Therapeutics Inc | Elisabeth A. Sandoval | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2021 | 20,500 | 20,500 | - | - | Stock Options |